# Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery

> **NCT00659945** · PHASE4 · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 150 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** Aprepitant plus Ondansetron
- **DRUG:** Ondansetron plus placebo

## Key facts

- **NCT ID:** NCT00659945
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2013-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659945, "Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00659945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*